Livforsakringsbolaget Skandia’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$51.8M Buy
211,806
+195,100
+1,168% +$45.4M 2.01% 9
2025
Q4
$3.46M Sell
16,706
-178,561
-91% -$35.3M 0.13% 112
2025
Q3
$36.2M Buy
195,267
+59,900
+44% +$10.3M 1.42% 9
2025
Q2
$20.7M Hold
135,367
0.9% 19
2025
Q1
$22.4M Hold
135,367
1.27% 11
2024
Q4
$19.6M Sell
135,367
-400
-0.3% -$62K 1.04% 14
2024
Q3
$22M Buy
135,767
+37,885
+39% +$6.04M 1.18% 12
2024
Q2
$14.3M Sell
97,882
-1,000
-1% -$149K 1.17% 12
2024
Q1
$15.6M Hold
98,882
1.32% 10
2023
Q4
$15.5M Buy
98,882
+2,345
+2% +$360K 1.48% 9
2023
Q3
$15M Sell
96,537
-4,627
-5% -$763K 1.65% 7
2023
Q2
$16.7M Sell
101,164
-10,000
-9% -$1.61M 1.74% 7
2023
Q1
$17.2M Hold
111,164
1.8% 5
2022
Q4
$19.6M Hold
111,164
2.25% 4
2022
Q3
$18.2M Sell
111,164
-31,600
-22% -$5.35M 2.24% 5
2022
Q2
$25.3M Sell
142,764
-9,000
-6% -$1.6M 2.21% 5
2022
Q1
$26.9M Buy
151,764
+1,900
+1% +$323K 1.8% 6
2021
Q4
$25.6M Sell
149,864
-9,400
-6% -$1.54M 1.63% 7
2021
Q3
$25.7M Sell
159,264
-7,400
-4% -$1.26M 1.61% 7
2021
Q2
$27.5M Buy
166,664
+12,600
+8% +$2.09M 1.64% 7
2021
Q1
$25.3M Buy
154,064
+18,200
+13% +$2.94M 1.76% 7
2020
Q4
$21.4M Buy
135,864
+10,400
+8% +$1.53M 1.81% 6
2020
Q3
$18.7M Sell
125,464
-1,900
-1% -$281K 2% 6
2020
Q2
$17.9M Buy
127,364
+800
+0.6% +$117K 2.05% 6
2020
Q1
$16.6M Buy
126,564
+7,200
+6% +$1.02M 2.33% 5
2019
Q4
$17.4M Sell
119,364
-9,900
-8% -$1.34M 2.07% 5
2019
Q3
$16.7M Hold
129,264
1.98% 6
2019
Q2
$18M Buy
129,264
+1,530
+1% +$212K 2.21% 5
2019
Q1
$17.9M Buy
127,734
+1,000
+0.8% +$134K 2.35% 4
2018
Q4
$16.4M Buy
126,734
+4,370
+4% +$610K 2.44% 4
2018
Q3
$16.9M Sell
122,364
-42,700
-26% -$5.67M 2.01% 5
2018
Q2
$20M Buy
165,064
+6,300
+4% +$786K 1.82% 5
2018
Q1
$20.3M Hold
158,764
1.97% 4
2017
Q4
$22.2M Sell
158,764
-19,000
-11% -$2.65M 2.12% 4
2017
Q3
$23.1M Sell
177,764
-2,756
-2% -$365K 2.07% 4
2017
Q2
$23.9M Hold
180,520
2.19% 3
2017
Q1
$22.5M Sell
180,520
-105,200
-37% -$12.6M 2.11% 3
2016
Q4
$32.9K Buy
285,720
+242,358
+559% +$28M 1.67% 5
2016
Q3
$1.04M Sell
43,362
-338,611
-89% -$41.1M 0.05% 449
2016
Q2
$46.3M Buy
381,973
+18,200
+5% +$2.07M 2.05% 3
2016
Q1
$39.4M Hold
363,773
1.85% 3
2015
Q4
$37.4M Buy
363,773
+47,000
+15% +$4.73M 1.76% 3
2015
Q3
$29.6M Hold
316,773
1.55% 5
2015
Q2
$30.9M Buy
316,773
+14,309
+5% +$1.43M 1.51% 4
2015
Q1
$30.4M Sell
302,464
-20,100
-6% -$2.04M 1.49% 5
2014
Q4
$33.7M Sell
322,564
-99,500
-24% -$10.5M 1.58% 4
2014
Q3
$45M Sell
422,064
-19,700
-4% -$2.04M 1.7% 4
2014
Q2
$46.2M Hold
441,764
1.66% 5
2014
Q1
$43.4M Buy
441,764
+413,464
+1,461% +$38.3M 1.63% 5
2013
Q4
$2.59M Sell
28,300
-8,829
-24% -$814K 1.68% 12
2013
Q3
$3.22M Hold
37,129
2.23% 6
2013
Q2
$3.19M Buy
+37,129
New +$3.15M 2.3% 7

Other funds holding JNJ

Livforsakringsbolaget Skandia's JNJ Position: Q1 2026 in Review

Livforsakringsbolaget Skandia increased its Johnson & Johnson (JNJ) stake by 1,168% in Q1 2026, buying an estimated $45.4M and bringing the position to 211,806 shares worth $51.8M. The position accounts for 2.01% of the portfolio, ranked #9.

Livforsakringsbolaget Skandia first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,632 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Livforsakringsbolaget Skandia held 211,806 shares of Johnson & Johnson worth $51.8M as of Q1 2026.
  • Livforsakringsbolaget Skandia bought 195,100 Johnson & Johnson shares in Q1 2026, an estimated $45.4M.
  • Johnson & Johnson made up 2.01% of Livforsakringsbolaget Skandia's portfolio in Q1 2026, its #9 holding.
  • Livforsakringsbolaget Skandia first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,632 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2026, filed 5 May 2026.